Clinical Drug Experience Knowledgebase

Arthritis, Rheumatoid (Phase 2)

Asthma (Phase 2)

Breast Neoplasms (Phase 2)

Bronchiolitis (Phase 1/Phase 2)

Bronchiolitis Obliterans (Phase 2)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 1)

Carcinoma, Transitional Cell (Phase 1)

Chondrosarcoma (Phase 1)

Colitis, Ulcerative (Phase 2)

Colorectal Neoplasms (Phase 1)

Cytokine Release Syndrome (Phase 2)

Endometrial Neoplasms (Phase 1)

Gastrointestinal Neoplasms (Phase 2)

Graft vs Host Disease (Phase 3)

Head and Neck Neoplasms (Phase 1)

Hematologic Neoplasms (Phase 1)

Hematopoietic Stem Cell Transplantation (Phase 2)

Hodgkin Disease (Phase 2)

Leiomyosarcoma (Phase 1)

Leukemia (Phase 1)

Leukemia, B-Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Plasma Cell (Phase 1)

Leukemia, Prolymphocytic, T-Cell (Phase 1)

Liposarcoma (Phase 1)

Lung Neoplasms (Phase 1/Phase 2)

Lymphohistiocytosis, Hemophagocytic (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 1)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 1/Phase 2)

Polycythemia Vera (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Primary Myelofibrosis (Phase 2)

Pruritus (Phase 2)

Psoriasis (Phase 2)

Sarcoma (Phase 1)

Sarcoma, Synovial (Phase 1)

Scleroderma, Systemic (Phase 2)

Thrombocytosis (Phase 2)